Strongest human evidence The METAOD006 (OPTIONS) Phase 2b trial randomized 502 adults with obesity (BMI 30-45 kg/m^2) to oral AOD-9604 (0.25, 0.5, or 1 mg/day) or placebo for 24 weeks alongside a supervised diet and exercise program
The FDA approved sermorelin (Geref, Serono) under NDA 19-559 for GH deficiency in children
& Martnez, V
Serious risks, including kidney strain, liver issues, allergic reactions, and rare cases of Stevens-Johnson syndrome, are linked to high doses, counterfeit vials, and unsupervised administration
For further information on proper storage techniques, click the link below: Peptide Storage BPC-157 5mg, TB-500 5mg (Wolverine Blend) (10 vials) is a laboratory research formulation used to study peptide behavior, signaling pathways, and multi-component cellular responses in controlled experimental systems
Patients should be counseled that current evidence supporting peptides is largely preclinical, that human surgical outcomes are poorly studied, and that product purity and sterility cannot be assumed